Lv4
740 积分 2023-05-04 加入
A-BRAVE trial: a phase III randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patients
17天前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
17天前
已完结
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2− breast cancer via CX3CR1+ macrophages
2个月前
已完结
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2− breast cancer via CX3CR1+ macrophages
2个月前
已完结
Plasma proteomic profiles predict future dementia in healthy adults
2个月前
已完结
Divergent biological pathways linking short and long sleep durations to mental and physical health
2个月前
已完结
Large-scale proteomic analyses of incident Parkinson’s disease reveal new pathophysiological insights and potential biomarkers
2个月前
已完结
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2− breast cancer via CX3CR1+ macrophages
9个月前
已完结
Utidelone Plus Bevacizumab for ERBB2-Negative Metastatic Breast Cancer and Active Brain Metastases
9个月前
已完结
Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy
9个月前
已完结
皖公网安备34019202002308